Anavex Completes Patient Enrollment for Phase 2a Alzheimer’s Trial Ahead of Schedule September 28, 2015
Anavex Receives Notice of Allowance for U.S. Patent Application Related to ANAVEX 2-73 August 12, 2015
Anavex Presents Positive Initial Phase 2a Study Data with ANAVEX 2-73 showing Early Evidence of Improving Cognition in Patients with Alzheimer’s Disease at AAIC 2015 July 22, 2015
Anavex to Present Initial Clinical Data from the Phase 2a Clinical Trial of ANAVEX 2-73 at the Alzheimer’s Association International Conference (AAIC) June 30, 2015
Anavex Encouraged by Data Showing Sigma-1 Receptor Reduces Tau Dysfunction, a Hallmark of Alzheimer’s Disease May 21, 2015
Anavex Releases Promising Full Preclinical Epilepsy Data at Antiepileptic Drug Trials XIII Conference May 18, 2015
